"Antiviral Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly.
| Descriptor ID |
D000998
|
| MeSH Number(s) |
D27.505.954.122.388
|
| Concept/Terms |
Antiviral Agents- Antiviral Agents
- Agents, Antiviral
- Antivirals
- Antiviral Drugs
- Drugs, Antiviral
|
Below are MeSH descriptors whose meaning is more general than "Antiviral Agents".
Below are MeSH descriptors whose meaning is more specific than "Antiviral Agents".
This graph shows the total number of publications written about "Antiviral Agents" by people in this website by year, and whether "Antiviral Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiviral Agents" by people in Profiles.
-
Monkeypox: A focused narrative review for emergency medicine clinicians. Am J Emerg Med. 2022 Nov; 61:34-43.
-
De novo emergence of SARS-CoV-2 spike mutations in immunosuppressed patients. Transpl Infect Dis. 2022 Dec; 24(6):e13914.
-
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management. Am J Emerg Med. 2022 Jun; 56:158-170.
-
Just the facts: updates in COVID-19 therapeutics. CJEM. 2021 May; 23(3):283-285.
-
Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV. Adv Exp Med Biol. 2021; 1318:149-167.
-
Just the facts: What drugs are safe and effective for COVID-19? CJEM. 2020 Sep; 22(5):591-594.
-
The ?4 subunit of Cav1.2 channels is required for an optimal interferon response in cardiac muscle cells. Sci Signal. 2018 12 11; 11(560).
-
Subtherapeutic ganciclovir (GCV) levels and GCV-resistant cytomegalovirus in lung transplant recipients. Transpl Infect Dis. 2014 Dec; 16(6):941-50.
-
Treatment of severe cases of pandemic (H1N1) 2009 influenza: review of antivirals and adjuvant therapy. Recent Pat Antiinfect Drug Discov. 2010 Jun; 5(2):152-6.
-
Shift shown in influenza A adamantane resistance. JAMA. 2006 Oct 04; 296(13):1585-6; author reply 1586-7.